NRXP•benzinga•June 5, 2025 at 12:10 PM

NRx Pharmaceuticals Announces Transmission Of Its Abbreviated New Drug Application To The U.S FDA For NRX-100, Its Preservative-Free IV Ketamine Formulation For Use In All Existing Approved Indications

No summary available.

Read the full article from the original source for complete details and context.

Article published on June 5, 2025 by benzinga